Salix Pharmaceuticals, Ltd. (SLXP)
$23.04
-0.25 (-1.07%)
| CAPS Rating |
|
|---|---|
| Open | $22.62 |
| Previous Close | $23.29 |
| Daily Range | $22.62 - $23.22 |
| 52-Week Range | $6.14 - $24.29 |
| Market Cap | $1.14B |
| P/E Ratio | 41.71 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 130,225 |
| Average Daily Volume | 830,000 |
SLXP
VS S&P 500 (SPY)
How do you think SLXP will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
SLXP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
SLXP News and Commentary
- Build Your Fortune With These Winners – The Motley Fool
- UPDATE 1-Salix posts narrower-than-expected Q3 loss – Reuters
- Get Ready for the Bounce – The Motley Fool
- 5 More Undiscovered Growth Stocks – The Motley Fool
Related News and Articles
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool
- 52-Week Highs! What's Going On? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- The Side Effect of Developing Obesity Drugs – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- Are These Dividends Too Good to Be True? – The Motley Fool
- This Baby Is a Nice Addition – The Motley Fool
RSS Headlines
Fool UK
